<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32138249</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1714</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21051714</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a complex multi-system neurodegenerative disorder with currently limited diagnostic and no therapeutic options. Despite the intense efforts no clinically applicable biomarkers for ALS are yet established. Most current research is thus focused, in particular, in identifying potential non-invasive circulating biomarkers for more rapid and accurate diagnosis and monitoring of the disease. In this review, we have focused on messenger RNA (mRNA), non-coding RNAs (lncRNAs), micro RNAs (miRNAs) and circular RNA (circRNAs) as potential biomarkers for ALS in peripheral blood serum, plasma and cells. The most promising miRNAs include miR-206, miR-133b, miR-27a, mi-338-3p, miR-183, miR-451, let-7 and miR-125b. To test clinical potential of this miRNA panel, a useful approach may be to perform such analysis on larger multi-center scale using similar experimental design. However, other types of RNAs (lncRNAs, circRNAs and mRNAs) that, together with miRNAs, represent RNA networks, have not been yet extensively studied in blood samples of patients with ALS. Additional research has to be done in order to find robust circulating biomarkers and therapeutic targets that will distinguish key RNA interactions in specific ALS-types to facilitate diagnosis, predict progression and design therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ravnik-Glava&#x10d;</LastName><ForeName>Metka</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glava&#x10d;</LastName><ForeName>Damjan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-9912-3331</Identifier><AffiliationInfo><Affiliation>Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P3-0054</GrantID><Agency>Javna Agencija za Raziskovalno Dejavnost RS</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073888" MajorTopicYN="N">Cell-Free Nucleic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">blood</Keyword><Keyword MajorTopicYN="N">ceRNET</Keyword><Keyword MajorTopicYN="N">circRNA</Keyword><Keyword MajorTopicYN="N">circulating RNAs</Keyword><Keyword MajorTopicYN="N">circulating biomarkers</Keyword><Keyword MajorTopicYN="N">lncRNA</Keyword><Keyword MajorTopicYN="N">mRNA</Keyword><Keyword MajorTopicYN="N">miRNA</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32138249</ArticleId><ArticleId IdType="pmc">PMC7084402</ArticleId><ArticleId IdType="doi">10.3390/ijms21051714</ArticleId><ArticleId IdType="pii">ijms21051714</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tandan R., Bradley W.G. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 1985;18:271&#x2013;280. doi: 10.1002/ana.410180302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410180302</ArticleId><ArticleId IdType="pubmed">4051456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S., Siddique T. Sporadic and hereditary amyotrophic lateral sclerosis (ALS) Biochim. Biophys. Acta. 2015;1852:679&#x2013;684. doi: 10.1016/j.bbadis.2014.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.08.010</ArticleId><ArticleId IdType="pubmed">25193032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chio A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet. Neurol. 2018;17:94&#x2013;102. doi: 10.1016/S1474-4422(17)30401-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30401-5</ArticleId><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 2009;65:S3&#x2013;S9. doi: 10.1002/ana.21543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21543</ArticleId><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Bentmann E., Dormann D., Jawaid A., DeJesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H.A., Munoz D.G., Kusaka H., et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain J. Neurol. 2011;134:2595&#x2013;2609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P., Rizzuti M., Faravelli I., Corti S. MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2018;55:2617&#x2013;2630. doi: 10.1007/s12035-017-0537-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0537-z</ArticleId><ArticleId IdType="pubmed">28421535</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Orrell R.W. Pathogenesis of amyotrophic lateral sclerosis. Br. Med. Bull. 2016;119:87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordone M.P., Salman M.M., Titus H.E., Amini E., Andersen J.V., Chakraborti B., Diuba A.V., Dubouskaya T.G., Ehrke E., Espindola de Freitas A., et al. The energetic brain&#x2014;A review from students to students. J. Neurochem. 2019;151:139&#x2013;165. doi: 10.1111/jnc.14829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14829</ArticleId><ArticleId IdType="pubmed">31318452</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen P.M., Abrahams S., Borasio G.D., de Carvalho M., Chio A., Van Damme P., Hardiman O., Kollewe K., Morrison K.E., Petri S., et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur. J. Neurol. 2012;19:360&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M., Boylan K., Jeromin A., Rutkove S.B., Berry J., Atassi N., Bruijn L. ALS biomarkers for therapy development: State of the field and future directions. Muscle Nerve. 2016;53:169&#x2013;182. doi: 10.1002/mus.24979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24979</ArticleId><ArticleId IdType="pmc">PMC4718795</ArticleId><ArticleId IdType="pubmed">26574709</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Karam C., Yu H., Gonterman F., Fetterman K.A., Cudkowicz M., Berry J., Wills A.M. Vitamin D levels are associated with gross motor function in amyotrophic lateral sclerosis. Muscle Nerve. 2017;56:726&#x2013;731. doi: 10.1002/mus.25555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25555</ArticleId><ArticleId IdType="pubmed">28044349</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Bowser R., Bruijn L., Dupuis L., Ludolph A., McGrath M., Manfredi G., Maragakis N., Miller R.G., Pullman S.L., et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:19&#x2013;32. doi: 10.3109/21678421.2013.778554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C., Hur J., Bender D.E., Delaney C.E., Cataldo M.D., Smith A.L., Yung R., Ruden D.M., Callaghan B.C., Feldman E.L. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52672. doi: 10.1371/journal.pone.0052672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052672</ArticleId><ArticleId IdType="pmc">PMC3530456</ArticleId><ArticleId IdType="pubmed">23300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Pacheco A., Franco J.M., Lopez S., Gomez-Zumaquero J.M., Magdalena Leal-Lasarte M., Caballero-Hernandez D.E., Cejudo-Guillen M., Pozo D. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis. Adv. Experimen. Med. Biol. 2017;978:255&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">28523551</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Yunusova Y., van Blitterswijk M., Dib S., Ghani M., Moreno D., Sato C., Liang Y., Singleton A., Robertson J., et al. Identical twins with the C9orf72 repeat expansion are discordant for ALS. Neurology. 2014;83:1476&#x2013;1478. doi: 10.1212/WNL.0000000000000886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000886</ArticleId><ArticleId IdType="pmc">PMC4206161</ArticleId><ArticleId IdType="pubmed">25209579</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P.E., Kum Jew S., Buckland M.E., Pamphlett R., Suter C.M. Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis. PLoS ONE. 2017;12:e0182638. doi: 10.1371/journal.pone.0182638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182638</ArticleId><ArticleId IdType="pmc">PMC5552194</ArticleId><ArticleId IdType="pubmed">28797086</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Xi Z., Ghani M., Jia P., Pal M., Werynska K., Moreno D., Sato C., Liang Y., Robertson J., et al. Genetic and epigenetic study of ALS-discordant identical twins with double mutations in SOD1 and ARHGEF28. J. Neurol. Neurosurg. Psychiatry. 2016;87:1268&#x2013;1270. doi: 10.1136/jnnp-2016-313592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-313592</ArticleId><ArticleId IdType="pubmed">27154192</ArticleId></ArticleIdList></Reference><Reference><Citation>Joilin G., Leigh P.N., Newbury S.F., Hafezparast M. An Overview of MicroRNAs as Biomarkers of ALS. Front. Neurol. 2019;10:186. doi: 10.3389/fneur.2019.00186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00186</ArticleId><ArticleId IdType="pmc">PMC6416171</ArticleId><ArticleId IdType="pubmed">30899244</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan J.J., Tay Y. Noncoding RNA:RNA Regulatory Networks in Cancer. Int. J. Mol. Sci. 2018;19:1310. doi: 10.3390/ijms19051310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051310</ArticleId><ArticleId IdType="pmc">PMC5983611</ArticleId><ArticleId IdType="pubmed">29702599</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzziello N., Liguori M. The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases. Cells. 2019;8:1193. doi: 10.3390/cells8101193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101193</ArticleId><ArticleId IdType="pmc">PMC6829202</ArticleId><ArticleId IdType="pubmed">31581723</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmena L., Poliseno L., Tay Y., Kats L., Pandolfi P.P. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 2011;146:353&#x2013;358. doi: 10.1016/j.cell.2011.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.07.014</ArticleId><ArticleId IdType="pmc">PMC3235919</ArticleId><ArticleId IdType="pubmed">21802130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M., Gijselinck I., Van Langenhove T., van der Zee J., Van Broeckhoven C. Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum. Trends Neurosci. 2013;36:450&#x2013;459. doi: 10.1016/j.tins.2013.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2013.04.010</ArticleId><ArticleId IdType="pubmed">23746459</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson S.B., Downie J.M., Tsetsou S., Feusier J.E., Figueroa K.P., Bromberg M.B., Jorde L.B., Pulst S.M. The evolving genetic risk for sporadic ALS. Neurology. 2017;89:226&#x2013;233. doi: 10.1212/WNL.0000000000004109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004109</ArticleId><ArticleId IdType="pmc">PMC5513819</ArticleId><ArticleId IdType="pubmed">28642336</ArticleId></ArticleIdList></Reference><Reference><Citation>Recabarren-Leiva D., Alarcon M. New insights into the gene expression associated to amyotrophic lateral sclerosis. Life Sci. 2018;193:110&#x2013;123. doi: 10.1016/j.lfs.2017.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.12.016</ArticleId><ArticleId IdType="pubmed">29241710</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk A.E., Weishaupt J.H., Andersen P.M., Ludolph A.C., Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med. Genet. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Embree L.J., Hickstein D.D. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 2000;20:3345&#x2013;3354. doi: 10.1128/MCB.20.10.3345-3354.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.10.3345-3354.2000</ArticleId><ArticleId IdType="pmc">PMC85627</ArticleId><ArticleId IdType="pubmed">10779324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S., Cleveland D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 2011;21:904&#x2013;919. doi: 10.1016/j.conb.2011.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2011.05.029</ArticleId><ArticleId IdType="pmc">PMC3228892</ArticleId><ArticleId IdType="pubmed">21813273</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Jr., Sapp P., McKenna-Yasek D., Brown R.H., Jr., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum. Mol. Genet. 2010;19:4160&#x2013;4175. doi: 10.1093/hmg/ddq335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq335</ArticleId><ArticleId IdType="pmc">PMC2981014</ArticleId><ArticleId IdType="pubmed">20699327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B. Regulated protein aggregation: Stress granules and neurodegeneration. Mol. Neurodegener. 2012;7:56. doi: 10.1186/1750-1326-7-56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-56</ArticleId><ArticleId IdType="pmc">PMC3519755</ArticleId><ArticleId IdType="pubmed">23164372</ArticleId></ArticleIdList></Reference><Reference><Citation>Niaki A.G., Sarkar J., Cai X., Rhine K., Vidaurre V., Guy B., Hurst M., Lee J.C., Koh H.R., Guo L., et al. Loss of Dynamic RNA Interaction and Aberrant Phase Separation Induced by Two Distinct Types of ALS/FTD-Linked FUS Mutations. Mol. Cell. 2020;77:82&#x2013;94. doi: 10.1016/j.molcel.2019.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.09.022</ArticleId><ArticleId IdType="pmc">PMC6943187</ArticleId><ArticleId IdType="pubmed">31630970</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., Weskamp K., Tank E.M., Li X., Miguez R., Dayton R.D., Tamir S., Klein R.L., et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606. doi: 10.1038/s41598-018-22858-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22858-w</ArticleId><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain J. Neurol. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R., Fani G., Bigi A., Chiti F., Cecchi C. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases. Int. J. Mol. Sci. 2019;20:3685. doi: 10.3390/ijms20153685.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20153685</ArticleId><ArticleId IdType="pmc">PMC6695586</ArticleId><ArticleId IdType="pubmed">31357627</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois-Moutal L., Perez-Miller S., Scott D.D., Miranda V.G., Mollasalehi N., Khanna M. Structural Insights Into TDP-43 and Effects of Post-translational Modifications. Front. Mol. Neurosci. 2019;12:301. doi: 10.3389/fnmol.2019.00301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00301</ArticleId><ArticleId IdType="pmc">PMC6934062</ArticleId><ArticleId IdType="pubmed">31920533</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Duguez S., Duddy W. Personalized Medicine and Molecular Interaction Networks in Amyotrophic Lateral Sclerosis (ALS): Current Knowledge. J. Pers. Med. 2018;8:44. doi: 10.3390/jpm8040044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm8040044</ArticleId><ArticleId IdType="pmc">PMC6313785</ArticleId><ArticleId IdType="pubmed">30551677</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., Aijo T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivova Z., Saarenpaa S., Saiz-Castro G., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science (New York) 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., Diekstra F.P., Harschnitz O., Westeneng H.J., van Eijk K.R., Saris C.G.J., Groen E.J.N., van Es M.A., Blauw H.M., van Vught P.W.J., et al. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;13:e0198874. doi: 10.1371/journal.pone.0198874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198874</ArticleId><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Saris C.G., Horvath S., van Vught P.W., van Es M.A., Blauw H.M., Fuller T.F., Langfelder P., DeYoung J., Wokke J.H., Veldink J.H., et al. Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients. BMC Genom. 2009;10:405. doi: 10.1186/1471-2164-10-405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-10-405</ArticleId><ArticleId IdType="pmc">PMC2743717</ArticleId><ArticleId IdType="pubmed">19712483</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi S., Zucca S., Pandini C., Diamanti L., Bordoni M., Sproviero D., Arigoni M., Olivero M., Pansarasa O., Ceroni M., et al. Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. Sci. Rep. 2018;8:2378. doi: 10.1038/s41598-018-20679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20679-5</ArticleId><ArticleId IdType="pmc">PMC5799454</ArticleId><ArticleId IdType="pubmed">29402919</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Manfellotto F., Fiorentino G., Annunziata A., Biffali E., Pannone R., Federico A. Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing. Front. Genet. 2018;9:310. doi: 10.3389/fgene.2018.00310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00310</ArticleId><ArticleId IdType="pmc">PMC6102490</ArticleId><ArticleId IdType="pubmed">30154826</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P.K., Prabhakar S., Abburi C., Sharma N.K., Anand A. Vascular endothelial growth factor-A and chemokine ligand (CCL2) genes are upregulated in peripheral blood mononuclear cells in Indian amyotrophic lateral sclerosis patients. J. Neuroinflamm. 2011;8:114. doi: 10.1186/1742-2094-8-114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-114</ArticleId><ArticleId IdType="pmc">PMC3177897</ArticleId><ArticleId IdType="pubmed">21906274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzma-Kozakiewicz M., Kazmierczak B., Chudy A., Gajewska B., Baranczyk-Kuzma A. Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis. Neuro-Degener. Dis. 2016;16:235&#x2013;244. doi: 10.1159/000443664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000443664</ArticleId><ArticleId IdType="pubmed">26954557</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachmany H., Wald S., Abekasis M., Bulvik S., Weil M. Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis. Dis. Markers. 2012;32:211&#x2013;220. doi: 10.1155/2012/824692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/824692</ArticleId><ArticleId IdType="pmc">PMC3826586</ArticleId><ArticleId IdType="pubmed">22430187</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadanand A., Janardhanan A., Vanisree A.J., Pavai T. Neurotrophin Expression in Lymphocytes: A Powerful Indicator of Degeneration in Parkinson&#x2019;s Disease, Amyotrophic Lateral Sclerosis and Ataxia. J. Mol. Neurosci. 2018;64:224&#x2013;232. doi: 10.1007/s12031-017-1014-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-017-1014-x</ArticleId><ArticleId IdType="pubmed">29247376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar U.G., Milla V., Cynthia Stafford M.Y., Bjourson A.J., Duddy W., Duguez S.M. A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS. Front. Neurol. 2019;10:400. doi: 10.3389/fneur.2019.00400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00400</ArticleId><ArticleId IdType="pmc">PMC6527847</ArticleId><ArticleId IdType="pubmed">31139131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirokawa N., Noda Y., Tanaka Y., Niwa S. Kinesin superfamily motor proteins and intracellular transport. Nat. Rev. Mol. Cell Biol. 2009;10:682&#x2013;696. doi: 10.1038/nrm2774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2774</ArticleId><ArticleId IdType="pubmed">19773780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercier V., Hubbard J.M., Fidelin K., Duroure K., Auer T.O., Revenu C., Wyart C., Del Bene F. Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Mol. Neurodegener. 2019;14:27. doi: 10.1186/s13024-019-0327-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0327-3</ArticleId><ArticleId IdType="pmc">PMC6617949</ArticleId><ArticleId IdType="pubmed">31291987</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti L., Dell&#x2019;Agnello C., Calvaresi N., Tortarolo M., Giorgini A., Coleman M.P., Bendotti C. Kif1Bbeta isoform is enriched in motor neurons but does not change in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. Res. 2003;71:732&#x2013;739. doi: 10.1002/jnr.10517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10517</ArticleId><ArticleId IdType="pubmed">12584731</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenck A., Bardoni B., Moro A., Bagni C., Mandel J.L. A highly conserved protein family interacting with the fragile X mental retardation protein (FMRP) and displaying selective interactions with FMRP-related proteins FXR1P and FXR2P. Proc. Natl. Acad. Sci. USA. 2001;98:8844&#x2013;8849. doi: 10.1073/pnas.151231598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.151231598</ArticleId><ArticleId IdType="pmc">PMC37523</ArticleId><ArticleId IdType="pubmed">11438699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrabec K., Bostjancic E., Koritnik B., Leonardis L., Dolenc Groselj L., Zidar J., Rogelj B., Glavac D., Ravnik-Glavac M. Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients. Front. Mol. Neurosci. 2018;11:106. doi: 10.3389/fnmol.2018.00106.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00106</ArticleId><ArticleId IdType="pmc">PMC5893848</ArticleId><ArticleId IdType="pubmed">29670510</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghunath M., Patti R., Bannerman P., Lee C.M., Baker S., Sutton L.N., Phillips P.C., Damodar Reddy C. A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line. Brain Res. Mol. Brain Res. 2000;77:151&#x2013;162. doi: 10.1016/S0169-328X(00)00048-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(00)00048-6</ArticleId><ArticleId IdType="pubmed">10837911</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomomura M., Hasegawa Y., Hashikawa T., Tomomura A., Yuzaki M., Furuichi T., Yano R. Differential expression and function of apoptosis-associated tyrosine kinase (AATYK) in the developing mouse brain. Brain Res. Mol. Brain Res. 2003;112:103&#x2013;112. doi: 10.1016/S0169-328X(03)00054-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(03)00054-8</ArticleId><ArticleId IdType="pubmed">12670708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuchner S., Noureddine M., Kennerson M., Verhoeven K., Claeys K., De Jonghe P., Merory J., Oliveira S.A., Speer M.C., Stenger J.E., et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat. Genet. 2005;37:289&#x2013;294. doi: 10.1038/ng1514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1514</ArticleId><ArticleId IdType="pubmed">15731758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitoun M., Maugenre S., Jeannet P.Y., Lacene E., Ferrer X., Laforet P., Martin J.J., Laporte J., Lochmuller H., Beggs A.H., et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat. Genet. 2005;37:1207&#x2013;1209. doi: 10.1038/ng1657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1657</ArticleId><ArticleId IdType="pubmed">16227997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinelli E., Pereira J.A., Suter U. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves. Hum. Mol. Genet. 2013;22:4417&#x2013;4429. doi: 10.1093/hmg/ddt292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt292</ArticleId><ArticleId IdType="pubmed">23813975</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Hooten K.G., Sieglaff D.H., Zhang A., Kalyana-Sundaram S., Traini C.M., Halsey W.S., Hughes A.M., Sathe G.M., et al. Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes. JAMA Neurol. 2017;74:677&#x2013;685. doi: 10.1001/jamaneurol.2017.0357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.0357</ArticleId><ArticleId IdType="pmc">PMC5822209</ArticleId><ArticleId IdType="pubmed">28437540</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., van den Berg L.H., Veldink J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.Y., Zhou Z.R., Che C.H., Liu C.Y., He R.L., Huang H.P. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori M., Nuzziello N., Introna A., Consiglio A., Licciulli F., D&#x2019;Errico E., Scarafino A., Distaso E., Simone I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018;11:288. doi: 10.3389/fnmol.2018.00288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00288</ArticleId><ArticleId IdType="pmc">PMC6121079</ArticleId><ArticleId IdType="pubmed">30210287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai R.S., Bhattacharyya S.N., Filipowicz W. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell Biol. 2007;17:118&#x2013;126. doi: 10.1016/j.tcb.2006.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2006.12.007</ArticleId><ArticleId IdType="pubmed">17197185</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier F., Marrero A., O&#x2019;Connell C., Morin P., Jr. MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis. J. Mol. Neurosci. 2015;56:102&#x2013;112. doi: 10.1007/s12031-014-0471-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0471-8</ArticleId><ArticleId IdType="pubmed">25433762</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel D.P. Metazoan MicroRNAs. Cell. 2018;173:20&#x2013;51. doi: 10.1016/j.cell.2018.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.006</ArticleId><ArticleId IdType="pmc">PMC6091663</ArticleId><ArticleId IdType="pubmed">29570994</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorn C.D., Kang M., Feigon J. Structure and function of preQ1 riboswitches. Biochim. Biophys. Acta. 2014;1839:939&#x2013;950. doi: 10.1016/j.bbagrm.2014.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2014.04.019</ArticleId><ArticleId IdType="pmc">PMC4177978</ArticleId><ArticleId IdType="pubmed">24798077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010;56:1733&#x2013;1741. doi: 10.1373/clinchem.2010.147405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.147405</ArticleId><ArticleId IdType="pmc">PMC4846276</ArticleId><ArticleId IdType="pubmed">20847327</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozomara A., Griffiths-Jones S. miRBase: Annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68&#x2013;D73. doi: 10.1093/nar/gkt1181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1181</ArticleId><ArticleId IdType="pmc">PMC3965103</ArticleId><ArticleId IdType="pubmed">24275495</ArticleId></ArticleIdList></Reference><Reference><Citation>Godlewski J., Lenart J., Salinska E. MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer. Non-Coding RNA. 2019;5:20. doi: 10.3390/ncrna5010020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5010020</ArticleId><ArticleId IdType="pmc">PMC6468660</ArticleId><ArticleId IdType="pubmed">30813461</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan S., Kenny A., Medina M., Engel T., Jimenez-Mateos E.M. MicroRNAs in Neurodegenerative Diseases. Int. Rev. Cell Mol. Biol. 2017;334:309&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pubmed">28838542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante M., Conti G.O. Environment and Neurodegenerative Diseases: An Update on miRNA Role. MicroRNA. 2017;6:157&#x2013;165. doi: 10.2174/2211536606666170811151503.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/2211536606666170811151503</ArticleId><ArticleId IdType="pubmed">28799488</ArticleId></ArticleIdList></Reference><Reference><Citation>Majdi A., Mahmoudi J., Sadigh-Eteghad S., Farhoudi M., Shotorbani S.S. The interplay of microRNAs and post-ischemic glutamate excitotoxicity: An emergent research field in stroke medicine. Neurol. Sci. 2016;37:1765&#x2013;1771. doi: 10.1007/s10072-016-2643-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-016-2643-5</ArticleId><ArticleId IdType="pubmed">27350638</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonrock N., Humphreys D.T., Preiss T., Gotz J. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J. Mol. Neurosci. 2012;46:324&#x2013;335. doi: 10.1007/s12031-011-9587-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9587-2</ArticleId><ArticleId IdType="pubmed">21720722</ArticleId></ArticleIdList></Reference><Reference><Citation>Banelli B., Forlani A., Allemanni G., Morabito A., Pistillo M.P., Romani M. MicroRNA in Glioblastoma: An Overview. Int. J. Genom. 2017;2017:7639084. doi: 10.1155/2017/7639084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7639084</ArticleId><ArticleId IdType="pmc">PMC5695025</ArticleId><ArticleId IdType="pubmed">29234674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao F., Qu Y., Zhu J., Zhang L., Huang L., Liu H., Li S., Mu D. miR-30d-5p Plays an Important Role in Autophagy and Apoptosis in Developing Rat Brains After Hypoxic-Ischemic Injury. J. Neuropathol. Experimen. Neurol. 2017;76:709&#x2013;719. doi: 10.1093/jnen/nlx052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx052</ArticleId><ArticleId IdType="pubmed">28789480</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Zhou Y., Zhang R., Wu K., Lu Y., Li Y., Duan R., Yao Y., Zhu D., Jia Y. MicroRNA Let-7f-5p Promotes Bone Marrow Mesenchymal Stem Cells Survival by Targeting Caspase-3 in Alzheimer Disease Model. Front. Neurosci. 2018;12:333. doi: 10.3389/fnins.2018.00333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00333</ArticleId><ArticleId IdType="pmc">PMC5972183</ArticleId><ArticleId IdType="pubmed">29872375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Yoon H., Chung D.E., Brown J.L., Belmonte K.C., Kim J. miR-186 is decreased in aged brain and suppresses BACE1 expression. J. Neurochem. 2016;137:436&#x2013;445. doi: 10.1111/jnc.13507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13507</ArticleId><ArticleId IdType="pmc">PMC4837067</ArticleId><ArticleId IdType="pubmed">26710318</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh S.E., Park H.J., He L., Skibiel C., Junn E., Mouradian M.M. The Parkinson&#x2019;s disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stress. Redox Biol. 2018;19:62&#x2013;73. doi: 10.1016/j.redox.2018.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2018.07.021</ArticleId><ArticleId IdType="pmc">PMC6092527</ArticleId><ArticleId IdType="pubmed">30107296</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimian N., Peymani M., Ghaedi K., Nasr Esfahani M.H. Modulation in miR-200a/SIRT1axis is associated with apoptosis in MPP(+)-induced SH-SY5Y cells. Gene. 2018;674:25&#x2013;30. doi: 10.1016/j.gene.2018.06.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.06.061</ArticleId><ArticleId IdType="pubmed">29936262</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Xu J., Wu M., Hu J.M. Protective role of microRNA-221 in Parkinson&#x2019;s disease. Bratisl. Lek. Listy. 2018;119:22&#x2013;27. doi: 10.4149/BLL_2018_005.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2018_005</ArticleId><ArticleId IdType="pubmed">29405726</ArticleId></ArticleIdList></Reference><Reference><Citation>Je G., Kim Y.S. Mitochondrial ROS-mediated post-transcriptional regulation of alpha-synuclein through miR-7 and miR-153. Neurosci. Lett. 2017;661:132&#x2013;136. doi: 10.1016/j.neulet.2017.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.09.065</ArticleId><ArticleId IdType="pubmed">28986122</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Lin F., Zhu P., Wu C., Zhao S., Han Q., Li X. Extract of Spatholobus suberctus Dunn ameliorates ischemia-induced injury by targeting miR-494. PLoS ONE. 2017;12:e0184348. doi: 10.1371/journal.pone.0184348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0184348</ArticleId><ArticleId IdType="pmc">PMC5589225</ArticleId><ArticleId IdType="pubmed">28880896</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin R., Xu S., Lin X., Shen M. MiR-136 controls neurocytes apoptosis by regulating Tissue Inhibitor of Metalloproteinases-3 in spinal cord ischemic injury. Biomed. Pharm. 2017;94:47&#x2013;54. doi: 10.1016/j.biopha.2017.07.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.07.053</ArticleId><ArticleId IdType="pubmed">28753453</ArticleId></ArticleIdList></Reference><Reference><Citation>Salta E., De Strooper B. microRNA-132: A key noncoding RNA operating in the cellular phase of Alzheimer&#x2019;s disease. FASEB J. 2017;31:424&#x2013;433. doi: 10.1096/fj.201601308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601308</ArticleId><ArticleId IdType="pubmed">28148775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkanjanawan T., Carter R.L., Prucha M.S., Yang J., Parnpai R., Chan A.W. miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington&#x2019;s Disease Monkey Neural Cells. PLoS ONE. 2016;11:e0162788. doi: 10.1371/journal.pone.0162788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0162788</ArticleId><ArticleId IdType="pmc">PMC5025087</ArticleId><ArticleId IdType="pubmed">27631085</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu M.H., Li C.L., Lin H.L., Tsai S.J., Lai Y.Y., Chang Y.F., Cheng P.H., Chen C.M., Yang S.H. The Potential Regulatory Mechanisms of miR-196a in Huntington&#x2019;s Disease through Bioinformatic Analyses. PLoS ONE. 2015;10:e0137637. doi: 10.1371/journal.pone.0137637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137637</ArticleId><ArticleId IdType="pmc">PMC4574104</ArticleId><ArticleId IdType="pubmed">26376480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang J.Y., Kaneko N., Noh K.M., Pontarelli F., Zukin R.S. The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die. J. Mol. Biol. 2014;426:3454&#x2013;3466. doi: 10.1016/j.jmb.2014.07.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2014.07.032</ArticleId><ArticleId IdType="pmc">PMC4373704</ArticleId><ArticleId IdType="pubmed">25108103</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ji B., Cheng B., Chen J., Bai B. Neuroprotection of microRNA in neurological disorders (Review) Biomed. Rep. 2014;2:611&#x2013;619. doi: 10.3892/br.2014.297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2014.297</ArticleId><ArticleId IdType="pmc">PMC4106625</ArticleId><ArticleId IdType="pubmed">25053999</ArticleId></ArticleIdList></Reference><Reference><Citation>Heman-Ackah S.M., Hallegger M., Rao M.S., Wood M.J. RISC in PD: The impact of microRNAs in Parkinson&#x2019;s disease cellular and molecular pathogenesis. Front. Mol. Neurosci. 2013;6:40. doi: 10.3389/fnmol.2013.00040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2013.00040</ArticleId><ArticleId IdType="pmc">PMC3834244</ArticleId><ArticleId IdType="pubmed">24312000</ArticleId></ArticleIdList></Reference><Reference><Citation>Junn E., Lee K.W., Jeong B.S., Chan T.W., Im J.Y., Mouradian M.M. Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. USA. 2009;106:13052&#x2013;13057. doi: 10.1073/pnas.0906277106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906277106</ArticleId><ArticleId IdType="pmc">PMC2722353</ArticleId><ArticleId IdType="pubmed">19628698</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Arisi I., D&#x2019;Ambrosi N., Storti A.E., Brandi R., D&#x2019;Onofrio M., Volonte C. Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation. Cell Death Dis. 2013;4:e959. doi: 10.1038/cddis.2013.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.491</ArticleId><ArticleId IdType="pmc">PMC3877562</ArticleId><ArticleId IdType="pubmed">24336079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L.Q., Guo G.L., Zhang S., Yang L.L. Effects of MicroRNA-592-5p on Hippocampal Neuron Injury Following Hypoxic-Ischemic Brain Damage in Neonatal Mice&#x2014;Involvement of PGD2/DP and PTGDR. Cell. Physiol. Biochem. 2018;45:458&#x2013;473. doi: 10.1159/000486923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000486923</ArticleId><ArticleId IdType="pubmed">29402808</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L., Wang J., Yuan Y., Zhang Y., Liu H., Wu C., Yan Y. MicRNA-320 facilitates the brain parenchyma injury via regulating IGF-1 during cerebral I/R injury in mice. Biomed. Pharm. 2018;102:86&#x2013;93. doi: 10.1016/j.biopha.2018.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.03.036</ArticleId><ArticleId IdType="pubmed">29549732</ArticleId></ArticleIdList></Reference><Reference><Citation>Harraz M.M., Eacker S.M., Wang X., Dawson T.M., Dawson V.L. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc. Natl. Acad. Sci. USA. 2012;109:18962&#x2013;18967. doi: 10.1073/pnas.1121288109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1121288109</ArticleId><ArticleId IdType="pmc">PMC3503176</ArticleId><ArticleId IdType="pubmed">23112146</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong R., Wang Z., Zhao Z., Li H., Chen W., Zhang B., Wang L., Wu L., Li W., Ding J., et al. MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration. Neurobiol. Aging. 2014;35:705&#x2013;714. doi: 10.1016/j.neurobiolaging.2013.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.027</ArticleId><ArticleId IdType="pubmed">24269020</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K., Yu B., Cheng C., Cheng T., Yuan B., Li K., Xiao J., Qiu Z., Zhou Y. Mir505-3p regulates axonal development via inhibiting the autophagy pathway by targeting Atg12. Autophagy. 2017;13:1679&#x2013;1696. doi: 10.1080/15548627.2017.1353841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2017.1353841</ArticleId><ArticleId IdType="pmc">PMC5640177</ArticleId><ArticleId IdType="pubmed">28820282</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng S.J., Zhang X.Q., Li J.T., Dai X.M., Zhao F. miRNA-223 regulates ischemic neuronal injury by targeting the type 1 insulin-like growth factor receptor (IGF1R) Folia Neuropathol. 2018;56:49&#x2013;57. doi: 10.5114/fn.2018.74659.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2018.74659</ArticleId><ArticleId IdType="pubmed">29663740</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichler S., Gu W., Hartl D., Gasparoni G., Leidinger P., Keller A., Meese E., Mayhaus M., Hampel H., Riemenschneider M. The miRNome of Alzheimer&#x2019;s disease: Consistent downregulation of the miR-132/212 cluster. Neurobiol. Aging. 2017;50:167.e1&#x2013;167.e10. doi: 10.1016/j.neurobiolaging.2016.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.09.019</ArticleId><ArticleId IdType="pubmed">27816213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Zhan Y., Ren N., Wang Z., Zhang Q., Wu S., Li H. Paraquat and MPTP alter microRNA expression profiles, and downregulated expression of miR-17-5p contributes to PQ-induced dopaminergic neurodegeneration. J. Appl. Toxicol. JAT. 2018;38:665&#x2013;677. doi: 10.1002/jat.3571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.3571</ArticleId><ArticleId IdType="pubmed">29250806</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.J., Ouyang Y.B., Xiong X., Stary C.M., Giffard R.G. Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia. Experimen. Neurol. 2015;264:1&#x2013;7. doi: 10.1016/j.expneurol.2014.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.11.007</ArticleId><ArticleId IdType="pmc">PMC4324354</ArticleId><ArticleId IdType="pubmed">25433215</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezache L., Mikhail M., Garofalo M., Nuovo G.J. Reduced miR-512 and the Elevated Expression of Its Targets cFLIP and MCL1 Localize to Neurons With Hyperphosphorylated Tau Protein in Alzheimer Disease. Appl. Immunohistochem. Mol. Morphol. 2015;23:615&#x2013;623. doi: 10.1097/PAI.0000000000000147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PAI.0000000000000147</ArticleId><ArticleId IdType="pubmed">26258756</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.B., Zhang Z., Li T.B., Lou Z., Li S.Y., Yang H., Yang J., Luo X.J., Peng J. Up-regulation of brain-enriched miR-107 promotes excitatory neurotoxicity through down-regulation of glutamate transporter-1 expression following ischaemic stroke. Clin. Sci. (Lond.) 2014;127:679&#x2013;689. doi: 10.1042/CS20140084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20140084</ArticleId><ArticleId IdType="pubmed">24943094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye M.L., Koval E.D., Wegener A.J., Hyman T.S., Yang C., O&#x2019;Brien D.R., Miller R.L., Cole T., Schoch K.M., Shen T., et al. MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models. J. Neurosci. 2017;37:5574&#x2013;5586. doi: 10.1523/JNEUROSCI.3582-16.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3582-16.2017</ArticleId><ArticleId IdType="pmc">PMC5452343</ArticleId><ArticleId IdType="pubmed">28416596</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O., Siddiqui S., Gabriely G., Lanser A.J., Dake B., Murugaiyan G., Doykan C.E., Wu P.M., Gali R.R., Iyer L.K., et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Investig. 2012;122:3063&#x2013;3087. doi: 10.1172/JCI62636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62636</ArticleId><ArticleId IdType="pmc">PMC3428086</ArticleId><ArticleId IdType="pubmed">22863620</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao P., Benito E., Fischer A. MicroRNAs as biomarkers for CNS disease. Front. Mol. Neurosci. 2013;6:39. doi: 10.3389/fnmol.2013.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2013.00039</ArticleId><ArticleId IdType="pmc">PMC3840814</ArticleId><ArticleId IdType="pubmed">24324397</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Guida M., Guida M., Coppola C., De Mieri G., Cotrufo R. A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene. 2012;508:35&#x2013;40. doi: 10.1016/j.gene.2012.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.07.058</ArticleId><ArticleId IdType="pubmed">22903028</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Ludolph A.C., Weishaupt J.H. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen J.M., Manzano R., Olivan S., Zaragoza P., Garcia-Redondo A., Osta R. MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e89065. doi: 10.1371/journal.pone.0089065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pmc">PMC3930686</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId></ArticleIdList></Reference><Reference><Citation>De Felice B., Annunziata A., Fiorentino G., Borra M., Biffali E., Coppola C., Cotrufo R., Brettschneider J., Giordana M.L., Dalmay T., et al. miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients. Neurogenetics. 2014;15:243&#x2013;253. doi: 10.1007/s10048-014-0420-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-014-0420-2</ArticleId><ArticleId IdType="pubmed">25130371</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Zondler L., Weydt P., Volk A.E., Bozic A.L., Walter M., Bonin M., Mayer B., von Arnim C.A., et al. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers. Brain J. Neurol. 2014;137:2938&#x2013;2950. doi: 10.1093/brain/awu249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu249</ArticleId><ArticleId IdType="pubmed">25193138</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Muller K., Zondler L., Weydt P., Mayer B., von Arnim C.A., Hubers A., Dorst J., Otto M., Holzmann K., et al. Serum microRNAs in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:2660.e15&#x2013;2660.e20. doi: 10.1016/j.neurobiolaging.2015.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.06.003</ArticleId><ArticleId IdType="pubmed">26142125</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi I., Hama Y., Matsushima M., Hirotani M., Kano T., Hohzen H., Yabe I., Utsumi J., Sasaki H. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Mol. Brain. 2015;8:67. doi: 10.1186/s13041-015-0161-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-015-0161-7</ArticleId><ArticleId IdType="pmc">PMC4619470</ArticleId><ArticleId IdType="pubmed">26497046</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Wei Q., Chen X., Li C., Cao B., Ou R., Hadano S., Shang H.F. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2016;9:69. doi: 10.3389/fnmol.2016.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00069</ArticleId><ArticleId IdType="pmc">PMC4987348</ArticleId><ArticleId IdType="pubmed">27582688</ArticleId></ArticleIdList></Reference><Reference><Citation>De Andrade H.M., de Albuquerque M., Avansini S.H., Rocha C.D.S., Dogini D.B., Nucci A., Carvalho B., Lopes-Cendes I., Franca M.C., Jr. MicroRNAs-424 and 206 are potential prognostic markers in spinal onset amyotrophic lateral sclerosis. J. Neurol. Sci. 2016;368:19&#x2013;24. doi: 10.1016/j.jns.2016.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2016.06.046</ArticleId><ArticleId IdType="pubmed">27538595</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E., Pegoraro V., Merico A., Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin. Neuropathol. 2016;35:22&#x2013;30. doi: 10.5414/NP300889.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300889</ArticleId><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheinerman K.S., Toledo J.B., Tsivinsky V.G., Irwin D., Grossman M., Weintraub D., Hurtig H.I., Chen-Plotkin A., Wolk D.A., McCluskey L.F., et al. Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases. Alzheimer&#x2019;s Res. 2017;9:89. doi: 10.1186/s13195-017-0316-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-017-0316-0</ArticleId><ArticleId IdType="pmc">PMC5679501</ArticleId><ArticleId IdType="pubmed">29121998</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R., Goodall E.F., Milo M., Cooper-Knock J., Da Costa M., Hobson E., Kazoka M., Wollff H., Heath P.R., Shaw P.J., et al. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS) Neurobiol. Aging. 2017;55:123&#x2013;131. doi: 10.1016/j.neurobiolaging.2017.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.03.027</ArticleId><ArticleId IdType="pmc">PMC5455071</ArticleId><ArticleId IdType="pubmed">28454844</ArticleId></ArticleIdList></Reference><Reference><Citation>Raheja R., Regev K., Healy B.C., Mazzola M.A., Beynon V., Von Glehn F., Paul A., Diaz-Cruz C., Gholipour T., Glanz B.I., et al. Correlating serum micrornas and clinical parameters in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:261&#x2013;269. doi: 10.1002/mus.26106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26106</ArticleId><ArticleId IdType="pmc">PMC6103911</ArticleId><ArticleId IdType="pubmed">29466830</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q., Zhao Y., Zhou X., Luan J., Cui Y., Han J. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis. Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamala J.M., Arias-Carrasco R., Sanchez C., Uhrig M., Bargsted L., Matus S., Maracaja-Coutinho V., Abarzua S., van Zundert B., Verdugo R., et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;64:123&#x2013;138. doi: 10.1016/j.neurobiolaging.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.020</ArticleId><ArticleId IdType="pubmed">29458840</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier D., Wajnberg G., Roy J., Beauregard A.P., Chacko S., Crapoulet N., Fournier S., Ghosh A., Lewis S.M., Marrero A., et al. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Brain Res. 2019;1708:100&#x2013;108. doi: 10.1016/j.brainres.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.12.016</ArticleId><ArticleId IdType="pubmed">30552897</ArticleId></ArticleIdList></Reference><Reference><Citation>Loeffler J.P., Picchiarelli G., Dupuis L., Gonzalez De Aguilar J.L. The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis. Brain Pathol. 2016;26:227&#x2013;236. doi: 10.1111/bpa.12350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12350</ArticleId><ArticleId IdType="pubmed">26780251</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Good P., Rasool C.G., Adelman L.S. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann. Neurol. 1983;14:267&#x2013;277. doi: 10.1002/ana.410140304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410140304</ArticleId><ArticleId IdType="pubmed">6195954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyck P.J., Stevens J.C., Mulder D.W., Espinosa R.E. Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves. Neurology. 1975;25:781&#x2013;785. doi: 10.1212/WNL.25.8.781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.25.8.781</ArticleId><ArticleId IdType="pubmed">1171412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2005;490:209&#x2013;219. doi: 10.1002/cne.20620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L., Lattanzi W., Bernardini C. Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2018;19:1534. doi: 10.3390/ijms19051534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051534</ArticleId><ArticleId IdType="pmc">PMC5983603</ArticleId><ArticleId IdType="pubmed">29786645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie M., Deng Z.L., Liu J., Wang D.Z. Noncoding RNAs, Emerging Regulators of Skeletal Muscle Development and Diseases. Biomed Res. Int. 2015;2015:676575. doi: 10.1155/2015/676575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/676575</ArticleId><ArticleId IdType="pmc">PMC4516831</ArticleId><ArticleId IdType="pubmed">26258142</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science (New York) 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Zhang F., Li L., Song B., Xu J., Wang G., Zheng Z. MiR-338-3p inhibits growth of glioblastoma through targeting MAP4K3. Minerva Med. 2019 doi: 10.23736/S0026-4806.19.06251-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.19.06251-7</ArticleId><ArticleId IdType="pubmed">31578840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Shi H., Ren F., Feng W., Cao Y., Li G., Liu Z., Ji P., Zhang M. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: Implication of Wnt/catenin beta and MEK/ERK signaling pathways. J. Exp. Clin. Cancer Res. 2019;38:494. doi: 10.1186/s13046-019-1494-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-019-1494-3</ArticleId><ArticleId IdType="pmc">PMC6916056</ArticleId><ArticleId IdType="pubmed">31842953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou T., Duan J., Liang J., Shi H., Zhen T., Li H., Zhang F., Dong Y., Han A. miR-338-3p suppresses colorectal cancer proliferation and progression by inhibiting MACC1. Int. J. Clin. Exp. Pathol. 2018;11:2256&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6958210</ArticleId><ArticleId IdType="pubmed">31938338</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe J.R., Li E.S., Streeter S.E., Rahme G.J., Chipumuro E., Russo G.B., Litzky J.F., Hills L.B., Rodgers K.R., Skelton P.D., et al. MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation. PLoS ONE. 2017;12:e0177661. doi: 10.1371/journal.pone.0177661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177661</ArticleId><ArticleId IdType="pmc">PMC5426787</ArticleId><ArticleId IdType="pubmed">28493990</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas J.C., Cuellar T.L., Scholze A., Ason B., Ibrahim A., Emery B., Zamanian J.L., Foo L.C., McManus M.T., Barres B.A. Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron. 2010;65:597&#x2013;611. doi: 10.1016/j.neuron.2010.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.01.027</ArticleId><ArticleId IdType="pmc">PMC2843397</ArticleId><ArticleId IdType="pubmed">20223197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., He X., Han X., Yu Y., Ye F., Chen Y., Hoang T., Xu X., Mi Q.S., Xin M., et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron. 2010;65:612&#x2013;626. doi: 10.1016/j.neuron.2010.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.02.018</ArticleId><ArticleId IdType="pmc">PMC2855245</ArticleId><ArticleId IdType="pubmed">20223198</ArticleId></ArticleIdList></Reference><Reference><Citation>Maragakis N.J., Dykes-Hoberg M., Rothstein J.D. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann. Neurol. 2004;55:469&#x2013;477. doi: 10.1002/ana.20003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20003</ArticleId><ArticleId IdType="pubmed">15048885</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Wei Q., Gu X., Chen Y., Chen X., Cao B., Ou R., Shang H. Decreased Glycogenolysis by miR-338-3p Promotes Regional Glycogen Accumulation Within the Spinal Cord of Amyotrophic Lateral Sclerosis Mice. Front. Mol. Neurosci. 2019;12:114. doi: 10.3389/fnmol.2019.00114.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00114</ArticleId><ArticleId IdType="pmc">PMC6514045</ArticleId><ArticleId IdType="pubmed">31133799</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Planelles C., Sanchez-Lozano P., Crespo M.C., Gil-Zamorano J., Ribacoba R., Gonzalez N., Suarez E., Martinez-Descals A., Martinez-Camblor P., Alvarez V., et al. Circulating microRNAs in Huntington&#x2019;s disease: Emerging mediators in metabolic impairment. Pharmacol. Res. 2016;108:102&#x2013;110. doi: 10.1016/j.phrs.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2016.05.005</ArticleId><ArticleId IdType="pubmed">27155059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Liang A.J., Fan Y.P., Huang Y.R., Zhao X.M., Sun Y., Chen X.F. Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis. Oncotarget. 2016;7:42805&#x2013;42825. doi: 10.18632/oncotarget.8715.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8715</ArticleId><ArticleId IdType="pmc">PMC5173173</ArticleId><ArticleId IdType="pubmed">27081087</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.L., Pan S.H., Yan J.J., Xu G. The prognostic value of microRNA-183 in human cancers: A meta-analysis. Medicine. 2018;97:e11213. doi: 10.1097/MD.0000000000011213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011213</ArticleId><ArticleId IdType="pmc">PMC6039630</ArticleId><ArticleId IdType="pubmed">29952976</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C.J., Chen H., Chen L.Z., Ru G.M., Guo J.J., Ding Q.N. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies. J. Cell. Biochem. 2018;119:2763&#x2013;2786. doi: 10.1002/jcb.26445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26445</ArticleId><ArticleId IdType="pmc">PMC5814937</ArticleId><ArticleId IdType="pubmed">29095529</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichiyama K., Dong C. The role of miR-183 cluster in immunity. Cancer Lett. 2019;443:108&#x2013;114. doi: 10.1016/j.canlet.2018.11.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2018.11.035</ArticleId><ArticleId IdType="pubmed">30529154</ArticleId></ArticleIdList></Reference><Reference><Citation>Banks S.A., Pierce M.L., Soukup G.A. Sensational MicroRNAs: Neurosensory Roles of the MicroRNA-183 Family. Mol. Neurobiol. 2020;57:358&#x2013;371. doi: 10.1007/s12035-019-01717-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-01717-3</ArticleId><ArticleId IdType="pubmed">31359323</ArticleId></ArticleIdList></Reference><Reference><Citation>Jawaid A., Woldemichael B.T., Kremer E.A., Laferriere F., Gaur N., Afroz T., Polymenidou M., Mansuy I.M. Memory Decline and Its Reversal in Aging and Neurodegeneration Involve miR-183/96/182 Biogenesis. Mol. Neurobiol. 2019;56:3451&#x2013;3462. doi: 10.1007/s12035-018-1314-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1314-3</ArticleId><ArticleId IdType="pubmed">30128653</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai H., Wu S. miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer. OncoTargets Ther. 2019;12:11069&#x2013;11082. doi: 10.2147/OTT.S230963.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S230963</ArticleId><ArticleId IdType="pmc">PMC6924581</ArticleId><ArticleId IdType="pubmed">31908476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronisz A., Chiocca E.A., Godlewski J. Response to energy depletion: miR-451/AMPK loop. Oncotarget. 2015;6:17851&#x2013;17852. doi: 10.18632/oncotarget.4606.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.4606</ArticleId><ArticleId IdType="pmc">PMC4627211</ArticleId><ArticleId IdType="pubmed">26257001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa D., Ansari K., Nowicki M.O., Salinska E., Bronisz A., Godlewski J. MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy. Non-Coding RNA. 2019;5:25. doi: 10.3390/ncrna5010025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5010025</ArticleId><ArticleId IdType="pmc">PMC6468936</ArticleId><ArticleId IdType="pubmed">30875963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Zhang H. miR-451 elevation relieves inflammatory pain by suppressing microglial activation-evoked inflammatory response via targeting TLR4. Cell Tissue Res. 2018;374:487&#x2013;495. doi: 10.1007/s00441-018-2898-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-018-2898-7</ArticleId><ArticleId IdType="pubmed">30069596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirshev E., Oberg K.C., Ioffe Y.J., Unternaehrer J.J. Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. Clin. Transl. Med. 2019;8:24. doi: 10.1186/s40169-019-0240-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40169-019-0240-y</ArticleId><ArticleId IdType="pmc">PMC6715759</ArticleId><ArticleId IdType="pubmed">31468250</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh S.Y., Chao Y.X., Dheen S.T., Tan E.K., Tay S.S. Role of MicroRNAs in Parkinson&#x2019;s Disease. Int. J. Mol. Sci. 2019;20:5649. doi: 10.3390/ijms20225649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20225649</ArticleId><ArticleId IdType="pmc">PMC6888719</ArticleId><ArticleId IdType="pubmed">31718095</ArticleId></ArticleIdList></Reference><Reference><Citation>Slota J.A., Booth S.A. MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications. Non-Coding RNA. 2019;5 doi: 10.3390/ncrna5020035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5020035</ArticleId><ArticleId IdType="pmc">PMC6632112</ArticleId><ArticleId IdType="pubmed">31022830</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.Y., Wang Y., Liu Q., Wu M. microRNA cluster MC-let-7a-1~let-7d promotes autophagy and apoptosis of glioma cells by down-regulating STAT3. CNS Neurosci. Ther. 2019;00:1&#x2013;13. doi: 10.1111/cns.13273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13273</ArticleId><ArticleId IdType="pmc">PMC7052808</ArticleId><ArticleId IdType="pubmed">31868319</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C., Napoli G., Amadio S., Spalloni A., Apolloni S., Longone P., Volonte C. MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ. 2016;23:531&#x2013;541. doi: 10.1038/cdd.2015.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.153</ArticleId><ArticleId IdType="pmc">PMC5072447</ArticleId><ArticleId IdType="pubmed">26794445</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes J.C.R., Acuna S.M., Aoki J.I., Floeter-Winter L.M., Muxel S.M. Long Non-Coding RNAs in the Regulation of Gene Expression: Physiology and Disease. Non-Coding RNA. 2019;5:17. doi: 10.3390/ncrna5010017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna5010017</ArticleId><ArticleId IdType="pmc">PMC6468922</ArticleId><ArticleId IdType="pubmed">30781588</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., Tsai M.C., Hung T., Argani P., Rinn J.L., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071&#x2013;1076. doi: 10.1038/nature08975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08975</ArticleId><ArticleId IdType="pmc">PMC3049919</ArticleId><ArticleId IdType="pubmed">20393566</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharap A., Nakka V.P., Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke. 2012;43:2800&#x2013;2802. doi: 10.1161/STROKEAHA.112.669465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.112.669465</ArticleId><ArticleId IdType="pmc">PMC3458128</ArticleId><ArticleId IdType="pubmed">22949471</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva P., Ratti A., Venturin M. The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis. Curr. Alzheimer Res. 2016;13:1219&#x2013;1231. doi: 10.2174/1567205013666160622112234.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666160622112234</ArticleId><ArticleId IdType="pubmed">27338628</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Williams N.G., Shelkovnikova T.A. NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found? Non-Coding RNA Res. 2018;3:243&#x2013;252. doi: 10.1016/j.ncrna.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.003</ArticleId><ArticleId IdType="pmc">PMC6257911</ArticleId><ArticleId IdType="pubmed">30533572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S., Lashley T., Norona F.E., Clayton E.L., Ridler C.E., Fratta P., Isaacs A.M. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol. 2013;126:845&#x2013;857. doi: 10.1007/s00401-013-1200-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1200-z</ArticleId><ArticleId IdType="pmc">PMC3830745</ArticleId><ArticleId IdType="pubmed">24170096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y., Nakagawa S., Hirose T., Okano H.J., Takao M., Shibata S., Suyama S., Kuwako K., Imai T., Murayama S., et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P.P., Sun X., Xia G., Arbez N., Paul S., Zhu S., Peng H.B., Ross C.A., Koeppen A.H., Margolis R.L., et al. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis. Ann. Neurol. 2016;80:600&#x2013;615. doi: 10.1002/ana.24761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24761</ArticleId><ArticleId IdType="pmc">PMC6555153</ArticleId><ArticleId IdType="pubmed">27531668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.L. The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol. 2016;17:205&#x2013;211. doi: 10.1038/nrm.2015.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.32</ArticleId><ArticleId IdType="pubmed">26908011</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong D., Sun H., Li Z., Liu S., Dong C., Fu K., Tang W., Cao H. An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget. 2017;8:73271&#x2013;73281. doi: 10.18632/oncotarget.19154.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.19154</ArticleId><ArticleId IdType="pmc">PMC5641211</ArticleId><ArticleId IdType="pubmed">29069868</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L., Mao M., Xiong K., Jiang B. Circular RNAs: A Novel Player in Development and Disease of the Central Nervous System. Front. Cell. Neurosci. 2017;11:354. doi: 10.3389/fncel.2017.00354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00354</ArticleId><ArticleId IdType="pmc">PMC5682331</ArticleId><ArticleId IdType="pubmed">29167634</ArticleId></ArticleIdList></Reference><Reference><Citation>Memczak S., Jens M., Elefsinioti A., Torti F., Krueger J., Rybak A., Maier L., Mackowiak S.D., Gregersen L.H., Munschauer M., et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333&#x2013;338. doi: 10.1038/nature11928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11928</ArticleId><ArticleId IdType="pubmed">23446348</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rossum D., Verheijen B.M., Pasterkamp R.J. Circular RNAs: Novel Regulators of Neuronal Development. Front. Mol. Neurosci. 2016;9:74. doi: 10.3389/fnmol.2016.00074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00074</ArticleId><ArticleId IdType="pmc">PMC4999478</ArticleId><ArticleId IdType="pubmed">27616979</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Alexandrov P.N., Jaber V., Lukiw W.J. Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer&#x2019;s Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7) Genes. 2016;7:116. doi: 10.3390/genes7120116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes7120116</ArticleId><ArticleId IdType="pmc">PMC5192492</ArticleId><ArticleId IdType="pubmed">27929395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sang Q., Liu X., Wang L., Qi L., Sun W., Wang W., Sun Y., Zhang H. CircSNCA downregulation by pramipexole treatment mediates cell apoptosis and autophagy in Parkinson&#x2019;s disease by targeting miR-7. Aging. 2018;10:1281&#x2013;1293. doi: 10.18632/aging.101466.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101466</ArticleId><ArticleId IdType="pmc">PMC6046232</ArticleId><ArticleId IdType="pubmed">29953413</ArticleId></ArticleIdList></Reference><Reference><Citation>Errichelli L., Dini Modigliani S., Laneve P., Colantoni A., Legnini I., Capauto D., Rosa A., De Santis R., Scarfo R., Peruzzi G., et al. FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons. Nat. Commun. 2017;8:14741. doi: 10.1038/ncomms14741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14741</ArticleId><ArticleId IdType="pmc">PMC5379105</ArticleId><ArticleId IdType="pubmed">28358055</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolinar A., Koritnik B., Glavac D., Ravnik-Glavac M. Circular RNAs as Potential Blood Biomarkers in Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2019;56:8052&#x2013;8062. doi: 10.1007/s12035-019-1627-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1627-x</ArticleId><ArticleId IdType="pmc">PMC6834740</ArticleId><ArticleId IdType="pubmed">31175544</ArticleId></ArticleIdList></Reference><Reference><Citation>Eom G.H., Kim K.B., Kim J.H., Kim J.Y., Kim J.R., Kee H.J., Kim D.W., Choe N., Park H.J., Son H.J., et al. Histone methyltransferase SETD3 regulates muscle differentiation. J. Biol. Chem. 2011;286:34733&#x2013;34742. doi: 10.1074/jbc.M110.203307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.203307</ArticleId><ArticleId IdType="pmc">PMC3186363</ArticleId><ArticleId IdType="pubmed">21832073</ArticleId></ArticleIdList></Reference><Reference><Citation>Tebar F., Bohlander S.K., Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: Localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol. Biol. Cell. 1999;10:2687&#x2013;2702. doi: 10.1091/mbc.10.8.2687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.10.8.2687</ArticleId><ArticleId IdType="pmc">PMC25500</ArticleId><ArticleId IdType="pubmed">10436022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudekula D.B., Panda A.C., Grammatikakis I., De S., Abdelmohsen K., Gorospe M. CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34&#x2013;42. doi: 10.1080/15476286.2015.1128065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2015.1128065</ArticleId><ArticleId IdType="pmc">PMC4829301</ArticleId><ArticleId IdType="pubmed">26669964</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Guan Y., Chen Y., Zhang C., Yu L., Gao H., Du H., Liu B., Wang X. miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice. Int. J. Clin. Exp. Pathol. 2013;6:1826&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759489</ArticleId><ArticleId IdType="pubmed">24040447</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishi K., Nishi A., Nagasawa T., Ui-Tei K. Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus. RNA. 2013;19:17&#x2013;35. doi: 10.1261/rna.034769.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.034769.112</ArticleId><ArticleId IdType="pmc">PMC3527724</ArticleId><ArticleId IdType="pubmed">23150874</ArticleId></ArticleIdList></Reference><Reference><Citation>Campos-Melo D., Droppelmann C.A., He Z., Volkening K., Strong M.J. Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: A role in the regulation of NFL mRNA levels. Mol. Brain. 2013;6:26. doi: 10.1186/1756-6606-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-26</ArticleId><ArticleId IdType="pmc">PMC3668997</ArticleId><ArticleId IdType="pubmed">23705811</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymick J.C., Scholz S.W., Fung H.C., Britton A., Arepalli S., Gibbs J.R., Lombardo F., Matarin M., Kasperaviciute D., Hernandez D.G., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol. 2007;6:322&#x2013;328. doi: 10.1016/S1474-4422(07)70037-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70037-6</ArticleId><ArticleId IdType="pubmed">17362836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen T.B., Jensen T.I., Clausen B.H., Bramsen J.B., Finsen B., Damgaard C.K., Kjems J. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384&#x2013;388. doi: 10.1038/nature11993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11993</ArticleId><ArticleId IdType="pubmed">23446346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawley Z.C.E., Campos-Melo D., Strong M.J. MiR-105 and miR-9 regulate the mRNA stability of neuronal intermediate filaments. Implications for the pathogenesis of amyotrophic lateral sclerosis (ALS) Brain Res. 2019;1706:93&#x2013;100. doi: 10.1016/j.brainres.2018.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2018.10.032</ArticleId><ArticleId IdType="pubmed">30385300</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>